Article
Researchers from the departments of dermatology at Wake Forest University Health Sciences and at the University of California, San Francisco, have developed a way to measure the impact that melasma has on health-related quality of life (HRQoL).
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
FDA Approves sNDA for Actinic Keratosis Drug Dosage Expansion
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
BREAKING NEWS: Additional Study Confirms Reports of Benzene Presence, Formation in Benzoyl Peroxide Products at Room Temperature
Derm In The News: September 29-October 5